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The retinoblastoma (Rb) protein negatively
regulates the G1-S transition by binding to
the E2F transcription factors, until cyclin-
dependentkinasesphosphorylateRb,caus-
ing E2F release. The Rb pocket domain is
necessary for E2F binding, but the Rb C-
terminal domain (RbC) is also required for
growth suppression. Here we demonstrate
a high-affinity interaction between RbC and
E2F-DP heterodimers shared by all Rb and
E2F family members. The crystal structure
of anRbC-E2F1-DP1complex reveals an in-
tertwined heterodimer in which the marked
box domains of both E2F1 and DP1 contact
RbC.We also demonstrate that phosphory-
lation of RbC at serines 788 and 795 desta-
bilizes one set of RbC-E2F-DP interactions
directly, while phosphorylation at threo-
nines 821 and 826 induces an intramolecu-
lar interaction between RbC and the Rb
pocket thatdestabilizes the remaining inter-
actions indirectly. Our findings explain the
requirement of RbC for high-affinity E2F
binding andgrowth suppression and estab-
lish a mechanism for the regulation of Rb-
E2F association by phosphorylation.
INTRODUCTION
The transition from the G1 to the S phases of the cell cycle
marks an irreversible commitment to DNA synthesis and
proliferation and is strictly regulated by positive and negative
growth-regulatory signals. The G1-S transition is controlled
by the Rb-E2F pathway, which links growth-regulatory path-Cellways to a transcription program required for DNA synthesis,
cell cycle progression, and cell division (Dyson, 1998;
Weinberg, 1995). This transcription program is activated by
the E2F transcription factors and repressed by E2F-Rb com-
plexes. E2F overexpression or Rb inactivation is sufficient to
induce S phase entry, whereas Rb overexpression can arrest
cycling cells in G1, demonstrating that the Rb-E2F pathway
is central to the control of the G1-S transition (Dyson, 1998;
Weinberg, 1995).
In quiescent cells or cells in early G1, the Rb protein binds
to the E2F transcription factors and blocks their transactiva-
tion domain. Rb also recruits transcriptional co-repressors
such as histone deacetylases (HDAC) and chromatin-
remodeling complexes, resulting in the repression of E2F-
responsive promoters (Dyson, 1998). Mitogenic growth fac-
tors lead to the sequential activation of the cyclin-dependent
kinase (Cdk)-Cyclin complexes Cdk4/6-CyclinD and Cdk2-
CyclinE, which hyperphosphorylate Rb and thereby cause
the release of active E2F (Dyson, 1998; Weinberg, 1995).
The Rb pathway thus ensures that S phase entry strictly de-
pends on growth-factor signals.
The importance of Rb in the control of cell proliferation is
underscored by the deregulation of this pathway in a majority
of cancer cases, which occurs either by mutation or deletion
of Rb, or by alterations in the upstream Cdk, Cyclin, and
Cdk-inhibitory proteins (Sherr, 1996; Weinberg, 1995). Rb
is also inactivated by DNA tumor viruses such as the human
papillomavirus (HPV), adenovirus, and the simian virus 40
(SV40), all of which express proteins that induce S phase
by binding to Rb and releasing active E2Fs (Nevins, 1994).
In humans, there are at least six closely related E2F pro-
teins (E2F1 through E2F6) and two Rb homologs (p107
and p130), which are commonly referred to as pocket pro-
teins. The E2F proteins have similar core DNA-sequence
specificity, but they differ in their ability to drive quiescent
cells into the cell cycle and in their relative promoter distribu-
tion in G1 and S (Trimarchi and Lees, 2002). E2F1 through
E2F3 are typically associated with active promoters in S
phase, while E2F4 through E2F6 with repressed promoters
in G0 or early G1. These differences are correlated with
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Figure 1. The C-Terminal Domains of the Rb and p107 Pocket Proteins Contain a General E2FCM-DPCM Binding Site
(A) Schematic representation of the previously described domains of E2F1, DP1, and Rb. The boundaries of the CC and MB domains are according to
results presented here.
(B) RbC binding is a general property of both E2F subfamilies, and both DP1 and DP2, which are closely related, support RbC-E2FCM-DPCM binding. Ten
micromolar purified His6RbC
771–928 was incubated with 10 mM of the indicated purified E2FCM-DPCM heterodimer or with the E2F transactivation domain
used as a negative control. Reactions were precipitated with Ni2+-NTA resin, and the unbound (U) and eluted bound (B) fractions were analyzed with SDS-
PAGE and Coomassie staining.
(C) E2FCM-DPCM binding is common to Rb and p107. The dissociation constants (Kd) for the binding of RbC or p107 to E2F1
CM-DP1CM and E2F4CM-DP1CM
complexes were determined by isothermal titration calorimetry (ITC) and calculated as the average and standard deviation from two to four independent
measurements (titration data are shown in Supplemental Data, Section 1). The RbCcore-E2FCM-DPCM interacting motif defined in this study is shown by
a box. For Rb, the locations of the Ser/Thr residues shown to be phosphorylated by Cdk-Cyclin complexes and of the reported docking sites for these
kinases are also indicated. The Rb C-terminal fragment used includes 15 residues from the end of the pocket structure, which is indicated by an arrow.
(D) RbCcore binds E2FCM-DPCM through a bipartite interaction. The dissociation constants for the binding of truncated RbC fragments to E2F1CM-DP1CM or
to E2F4CM-DP2CM were determined by ITC as in (C).(Trimarchi and Lees, 2002). E2F1, E2F2, and E2F3 are found
associated with Rb, and E2F5 with p130. E2F4, which is the
most abundant family member, is found associated primarily
with p107 and to a lesser extent with Rb and p130. E2F pro-
teins form heterodimers with one of two DP proteins, which
are distantly related to the E2F proteins. Heterodimerization
has been shown to enhance the Rb binding, DNA binding,
and transactivation activities of E2Fs (Bandara et al., 1994;
Helin et al., 1993b; Krek et al., 1993).
The six E2F and two DP family members all contain a DNA
binding domain (DBD), predicted coiled-coil (CC) domain,
and marked-box (MB) domain (Figure 1A). The transactiva-
tion domain (TD) is present only in E2F1 through E2F5. Rb
contains a 379 residue N-terminal domain of unknown func-
tion, a 406 residue middle domain commonly referred to as
the pocket, and a 143 residue C-terminal domain (RbC; Fig-
ure 1A). The pocket domain, which is best conserved among1094 Cell 123, 1093–1106, December 16, 2005 ª2005 Elsevier InRb paralogs, directly binds to and blocks the E2F transacti-
vation domain (Flemington et al., 1993; Helin et al., 1993a).
The pocket of Rb is necessary but not sufficient for growth
suppression, which additionally requires RbC (Qin et al.,
1992). RbC is also required for high-affinity binding to
E2F-DP complexes and for maximal repression of E2F-
responsive promoters (Hiebert, 1993; Hiebert et al., 1992;
Qin et al., 1992). The importance of the RbC domain is reca-
pitulated in the Rb paralogs p107 and p130, which have
conserved sequences C-terminal to their pocket domains
that are required for growth suppression, high-affinity bind-
ing to their preferred E2F-DP complexes, and maximal re-
pression of E2F-responsive promoters (Zhu et al., 1995).
These observations suggest a role for the C-terminal do-
mains of Rb and its paralogs in E2F-DP binding.
A general RbC-E2F-DP interaction has also been sug-
gested by studies of the HPV E7, adenovirus E1A, andc.
SV40 large tumor antigen proteins that cause the release of
E2F. These proteins share a common LxCxE sequence motif
that binds to the Rb pocket domain with high affinity but does
not cause the release of E2F (Patrick et al., 1994; Raychaud-
huri et al., 1991; Zalvide et al., 1998). E2F release requires
additional viral-protein domains, which in the case of HPV
E7 has been shown to bind RbC (Patrick et al., 1994). In ad-
dition, the adenovirus E4-6/7 protein, which blocks the as-
sociation of E2F with Rb, has been shown to bind to the
E2F MB domain (Jost et al., 1996; O’Connor and Hearing,
1994). Taken together, these findings raised the possibility
that RbC binds to the E2F MB domain and that interference
with this association contributes to the release of E2F by viral
proteins. A recent study showed that an Rb C-terminal frag-
ment can bind to a truncated E2F1 protein that lacks the
transactivation domain (Dick and Dyson, 2003). However,
this interaction was shown to be E2F1 specific and was im-
plicated in an apoptotic function unique to E2F1.
The mechanism through which E2F is dissociated by Rb
hyperphosphorylation has not been well understood, but
most studies point to a hierarchical series of Rb phosphory-
lation events cumulatively affecting the stability of the Rb-
E2F complex (Brown et al., 1999; Chellappan et al., 1991;
Harbour et al., 1999; Knudsen and Wang, 1997; Lundberg
and Weinberg, 1998). Six of the sixteen consensus Cdk
phosphorylation sites of Rb map to the RbC, raising the pos-
sibility that if a general RbC-E2F interaction does exist, it may
be involved in the phosphorylation-induced release of E2F.
Here, we demonstrate an interaction between RbC and
the CC-MB domains of E2F-DP heterodimers and present
the crystal structure of an RbC-E2F1-DP1 complex. The
structure in conjunction with biochemical and biophysical
data indicate that the RbC-E2F-DP interaction (1) is shared
by all E2F and Rb family members, (2) contributes to the pre-
ference of p107/p130 for the E2F4 subfamily, and (3) is neg-
atively regulated by RbC hyperphosphorylation.
RESULTS
An RbC-E2F-DP Interaction Common to Rb
and E2F-DP Family Members
To investigate the possibility of a general interaction between
the C-terminal domains of the pocket proteins and the MB
domains of their respective E2F-DP partners, we first used
limited proteolysis to better define the structural organization
of the E2F-DP heterodimer. Extending previous work show-
ing that the E2F-DP DNA binding domains are connected to
the CC-domains through an five residue flexible linker
(Zheng et al., 1999), we found that the E2F2-DP1 hetero-
dimer has a protease-resistant structural domain consisting
of residues 209–304 of E2F2 and 199–350 of DP1 (data not
shown). These fragments include the CC and MB domains,
shown to be required for E2F-DP heterodimerization (Helin
et al., 1993b) and notably lack the E2F transactivation do-
main (Figure 1A).
We assessed whether this E2F2-DP1 heterodimer (here-
after E2F2CM-DP1CM) or the corresponding E2F1CM-
DP1CM, E2F4CM-DP2 CM, and E2F5CM-DP1CM heterodimers
bind RbC using a Ni2+-His6 affinity-precipitation assay. ForCellthis experiment, we used an Rb fragment (residues 771–
928; hereafter RbC771–928) that contains RbC and the pre-
ceding 15 residue region from the end of the pocket domain.
We incubated 10 mM purified His6RbC
771–928 with 10 mM of
each purified E2FCM-DPCM heterodimer, precipitated it using
Ni2+-NTA resin, eluted it with imidazole, and analyzed
His6RbC
771–928 bound proteins with SDS-PAGE and Coo-
massie staining. Figure 1B shows that RbC771–928 bound
all four E2FCM-DPCM heterodimers but did not bind the
E2F1 transactivation domain used as a negative control.
We next measured the affinity of the RbC-E2FCM-DPCM in-
teraction using isothermal titration calorimetry (ITC; see data
in the Supplemental Data, Section 1, available with this arti-
cle online). We found that RbC771–928 binds to the E2F1CM-
DP1CM complex with a dissociation constant (Kd) of 110 ±
50 nM (standard deviation from four independent measure-
ments) and to the E2F4CM-DP1CM complex with a Kd of
190 ± 130 nM (SD from two experiments; Figure 1C). These
Kd values are comparable to the Rb pocket domain-E2F1
transactivation domain Kd, which has been reported to be
340 nM and 400 nM in two independent ITC studies (Lee
et al., 1998; Xiao et al., 2003). Our ITC data thus indicate
that the RbC-E2FCM-DPCM interaction could be as important
as the pocket-transactivation domain interaction for the for-
mation of the Rb-E2F-DP complex. We suggest this obser-
vation provides an adequate explanation for the significant
body of literature showing that RbC is required for high-
affinity E2F-DP binding, for full repression of E2F-responsive
promoters, and ultimately for growth suppression (Hiebert,
1993; Hiebert et al., 1992; Qin et al., 1992). In addition,
the dissociation constants for the binding of RbC to the
E2F1CM-DP1CM and the E2F4CM-DP1CM complexes are
comparable within experimental error. Taken together with
the Ni2+ precipitation data, these findings indicate that the
ability to bind RbC is shared by the E2F1 and E2F4 subfami-
lies and both DP1 and DP2.
We next investigated whether p107 has a similar E2FCM-
DPCM binding activity. The C-terminal domain of p107 and
its close homolog p130 share only limited sequence homol-
ogy with RbC, but like RbC, the p107 C terminus is required
for growth suppression and high-affinity E2F binding (Zhu
et al., 1995). Using ITC, we tested the binding of a p107 frag-
ment encompassing the entire sequence following the
pocket domain (residues 949–1068; hereafter p107C) to
E2F-DP complexes. Figure 1C shows that p107C binds to
the E2F4CM-DP1CM complex tightly with a Kd of 0.8 ±
0.1 mM and to the E2F1CM-DP1CM complex weakly with
a Kd of 5.0 ± 0.8 mM. Taken together, our data indicate
that E2FCM-DPCM binding is an activity common to the
C-terminal domains of both Rb and p107 and that this activ-
ity contributes to the preference of p107 for E2F4 (Trimarchi
and Lees, 2002).
RbC Binds to E2FCM-DPCM through a Bipartite
Interaction
Limited proteolysis of an Rb protein containing the pocket
and RbC domains suggested that RbC does not contain sta-
ble structural domains (data not shown), and NMR data
indicate that the isolated RbC is unstructured in solution123, 1093–1106, December 16, 2005 ª2005 Elsevier Inc. 1095
(Supplemental Data, Section 2). We thus made successive
N- and C-terminal truncations guided by sequence conser-
vation to map the RbC region(s) involved in E2FCM-DPCM
binding. The affinities of these Rb fragments for E2F1CM-
DP1CM were determined using ITC, and the results are listed
in Figure 1D.
Deletion of the C-terminal 54 residues (875–928), shown
to contain docking sites for the Cdk2-CyclinA/E and Cdk4/
6-CyclinD binding complexes (Adams et al., 1999; Pan
et al., 2001; Wallace and Ball, 2004), had no effect on the af-
finity for E2F1CM-DP1CM (RbC771–874 Kd = 0.15 ± 0.02 mM),
indicating that these residues are not involved in E2F1CM-
DPCM binding. Deletion of the N-terminal 15 residues (771–
785) that are part of the Rb pocket crystal structure (Lee
et al., 1998) also had no effect on the affinity (RbC786–874
Kd = 0.13 ± 0.02 mM).
Deletion of the next 15 N-terminal residues of RbC (786-
800) decreased the affinity by a factor of 36 (RbC801–874
Kd = 4 ± 1 mM), indicating that residues 786–800 are involved
in E2F1CM-DP1CM binding. Further N-terminal deletions
until residue 829 had no additional effect on the affinity
(RbC814–874 Kd = 4.8 ± 0.9 mM and RbC
829–874 Kd = 4.9 ±
3 mM). In light of the crystal structure described below,
we made one additional C-terminal deletion of residues
865–874 and found that they are uninvolved in binding
(RbC814–864 Kd = 5.2 ± 0.8 mM). Taken together, these
data indicated that RbC contains two discontinuous regions
that interact with E2F1CM-DP1CM. A core region between
residues 829–864 (hereafter RbCcore) binds with a Kd of
5 mM, while a secondary region within residues 786–800
(hereafter RbCnter) contributes a 36-fold increase in affinity.
This bipartite mode of RbC-E2F1-DP1 binding is mirrored
in the binding of RbC to E2F4-DP1/2. As shown in Fig-
ure 1D, deletion of RbCnter reduces the affinity of RbC for
E2F4CM-DP2CM 25-fold (RbC814–874 Kd = 5.0 ± 0.8 mM com-
pared to 0.19 mM for RbC771–874).
Building on these findings, we obtained crystals of a ternary
complex consisting of RbC829–874, which contains RbCcore
but lacks RbCnter, bound to the E2F1CM-DP1CM heterodimer.
The structure was determined by the multiwavelength anom-
alous diffraction (MAD) method using data from a selenome-
thionine-substituted complex and was refined at 2.55 A˚ res-
olution (Table 1). The refined model contains residues 829–
872 of Rb, residues 201–301 of E2F1, and residues 199–
346 of DP1.
Overall Structure of the E2F1CM-DP1CM-RbCcore
Complex
The E2F1CM-DP1CM heterodimer has an intertwined struc-
ture consisting of an intermolecular coiled coil, an intermolec-
ular b sandwich, and several additional structural elements
(Figure 2A). The coiled coil is formed by a 35 residue helix
(eH1) from the E2F1 CC domain and a 48 residue helix
(dH1) from the DP1 CC domain. The N-terminal half of the
coiled coil has a canonical arrangement of helices (Lupas,
1996), but the remainder has larger helix-helix distances as-
sociated with contacts to other parts of the complex.
The intermolecular b sandwich structure is similar to the
immunoglobulin fold (Bork et al., 1994). It consists of two1096 Cell 123, 1093–1106, December 16, 2005 ª2005 Elsevier Infour-stranded b sheets that pack across a mixed hydropho-
bic core involving both E2F1 and DP1 side chains (Figure 2A).
Each sheet has a pair of strands from E2F1 and a pair of
strands from DP1 (eS2, eS5, dS2, dS5 on one sheet and
eS3, eS4, dS3, dS4 on the other; Figures 2A and 2B).
In addition to the intermolecular coiled coil andb sandwich,
E2F1CM-DP1CM contains five additional a helices (eH2, eH3,
and dH2 to dH4) and a short two-stranded b sheet (eS1 and
dS1; Figures 2A and 3A). These occur at nonanalogous po-
sitions in the E2F1 and DP1 primary sequences and in the ter-
tiary structure (Figures 2A and 2B). Although both the coiled
coil and b sandwich have 2-fold pseudosymmetry, the struc-
ture of the overall complex is asymmetric due to the location
of the coiled coil at one end of the b sandwich and the non-
analogous E2F1 and DP1 helices.
The RbC fragment adopts a 32 residue strand-loop-helix
structure followed by a 20 residue tail segment that lacks reg-
ular secondary structure (Figures 2A and 2B). The strand-
loop-helix motif (rS1 and rH1) binds to one side of the b sand-
wich and interacts with both E2F1 and DP1. The rS1 strand
extends one of the E2F1-DP1 b sheets by forming a fifth
b strand alongside of eS3, while the rH1 helix packs against
the partially exposed hydrophobic core of the b sandwich.
Following the rH1 helix, the RbC tail loops around one end
of the b sandwich, making additional contacts with E2F1
and DP1.
E2F1CM-DP1CM Interactions and Preference
for Heterodimerization
The E2F1-DP1 heterodimer interface buries 6300 A˚2 of
surface area compared to the hypothetical isolated mono-
mers of the same structure. Intermolecular interactions are
distributed throughout the E2F1 and DP1 polypeptides and
involve the coiled coil, the b sandwich, and essentially all of
the additional secondary-structure elements (Figures 2A
and 2B). These additional structural elements also help an-
chor the coiled coil to the b sandwich (Figure 3A). The E2F1
and DP1 residues that make intermolecular contacts are ei-
ther identical or conservatively substituted in their respective
families (Figure 2B), consistent with observations that both
DP1 and DP2 can heterodimerize with the first six E2F paral-
ogs (Trimarchi and Lees, 2002).
The E2F1-DP1 interactions revealed by the crystal struc-
ture have several implications for understanding the prefer-
ence of E2F proteins to form heterodimers with DP proteins
and also help address the question of whether E2F proteins
can form functional homodimers (Bandara et al., 1993;
Helin et al., 1993b; Huber et al., 1993; Krek et al., 1993).
We note that unlike the intermolecular coiled coil and b
sandwich that are related by a 2-fold pseudosymmetry,
many interactions involve nonanalogous structural elements
of E2F and DP. For example, the E2F-specific eH2 helix in-
teracts with dH1, and the E2F-specific eH3 helix interacts
with dS4 and with the DP-specific dH2 (Figure 3A). These
observations suggest that if E2F could form a homodimer,
its structure would be significantly different from that of
E2F1-DP1.
Even within the coiled coil, the intermolecular interactions
often involve noninterchangeable hydrophobic and chargedc.
Table 1. Statistics from the Crystallographic Analysis
Data Set Native Se l1 Se l2 Se l3
Beamline ID24 (APS) X4A (NSLS) X4A (NSLS) X4A (NSLS)
Wavelength (A˚) 0.94980 0.97916 0.97241 0.97929
Resolution (A˚) 2.55 2.7 2.7 2.7
Observations 71,304 188,703 191,178 138,084
Unique reflections 19,350 35,326 35,584 36,140
Data coverage (%) 97.8 99.3 99.5 98.5
Rsym (%) (last shell: 2.55–2.64, 2.70–2.79) 5.3 (42.5) 6.1 (27.4) 6.1 (32.6) 5.6 (40.2)
MAD Analysis
Resolution 20–3.0 20–3.0 20–3.0
Phasing power 1.09 1.62 —
Rcullis 0.83 0.69 —
Anomalous Rcullis 0.52 0.57 0.64
Mean FOM 0.68
Refinement Statistics
Resolution range (A˚) 15.0–2.55
Reflections (|F|>0s) 17,600
Total atoms 2459
Number of water molecules 131
R factor (%) (last shell: 2.55–2.62) 22.1 (27.3)
Rfree (%) (last shell: 2.55–2.62) 26.2 (28.4)
Rmsd
Bonds (A˚) 0.009
Angles (º) 1.157
B factor (A˚2) Main chain bond 1.47 Side chain bond 2.58
Rsym = ShSi |Ih,I  Ih|/ShSi Ih,i for the intensity (I) of i observations of reflection h. Phasing power = <Fli>/E, where <Fli> is the rms heavy
atom structure factor and E is the residual lack of closure error. Rcullis is the mean residual lack of closure error divided by the dispersive or
anomalous difference. R factor = S||Fobs|  |Fcalc||/S|Fobs|, where Fobs and Fcalc are the observed and calculated structure factors, re-
spectively. Rfree = R factor calculated using 5% of the reflection data chosen randomly and omitted from the start of refinement.
Rmsd., root-mean-square deviations from ideal geometry and variations in the B factor of bonded atoms.residues of E2F1 and DP1 (Supplemental Data, Section 3).
For example, the acidic and basic residues that form inter-
molecular salt bridges are segregated to E2F1 and DP1, re-
spectively. Such salt bridges play an important role in the
preference of coiled coils to heterodimerize rather than ho-
modimerize (Lupas, 1996). These observations suggest
that if E2F could form a homodimeric coiled coil, its stability
would be significantly lower than that of the E2F1-DP1hetero-
dimer.
To test this hypothesis, we assessed the binding of His6-
tagged E2F1CM to either E2F1CM or DP1CM using the Ni2+
affinity precipitation assay as described for Figure 1B. We in-
cubated 10 mM His6E2F1
CM with 10 mM of either the corre-
sponding untagged E2F1CM-DP1CM complex or untagged
E2F1CM for 24 hr to allow for partial exchange. Figure 3B
shows that His6E2F1
CM bound approximately one-third ofCellthe total DP1CM in the reaction containing E2F1CM-DP1CM
but did not bind a detectable amount of E2F1CM (Fig-
ure 3B, lane 6). These data indicate a strong preference to
form heterodimers over homodimers. When we incubated
His6E2F1
CM with untagged E2F1CM only, we could not detect
any E2F1CM (Figure 3B, lane 8). We obtained similar results
when the proteins were corefolded from urea (data not
shown). In addition, NMR data suggest that E2F1CM is un-
structured in the absence of DP1 (Supplemental Data, Sec-
tion 2). These results confirm the structure-based prediction
that the E2F1CM homodimer is less stable than the E2F1CM-
DP1CM heterodimer, and they provide an explanation for the
observation that the DNA binding and transactivation activi-
ties of E2F1 are reduced in the absence of a DP partner
(Bandara et al., 1993; Helin et al., 1993b; Huber et al., 1993;
Krek et al., 1993; Zheng et al., 1999).123, 1093–1106, December 16, 2005 ª2005 Elsevier Inc. 1097
Figure 2. Overall structure and sequence alignment of the RbCcore-E2F1CM-DP1CM ternary complex
(A) E2F1CM (red) and DP1CM (blue) form an intertwined structure where both E2F1 and DP1 contact RbCcore (orange). Also shown is the E2F1CM-DP1CM
topology diagram.
(B) Top panel shows sequence alignment of human E2FCM and DPCM family members. Lower panel shows sequence alignment of human (hs), mouse (mm),
chicken (gg), frog (xl), and fugu (fr) RbC orthologs and of the human p107 and p130 Rb family members. Residues that are conserved among p107 and p130
orthologs are colored in cyan (see Supplemental Data, Section 4). Residues that make intermolecular contacts and the Rb/p107/p130 phosphorylation sites
are marked. The positions of the RbCnter and RbCcore motifs determined in this study are indicated by dotted boxes.RbCcore-E2F1CM-DP1CM Interactions
The RbC fragment binds to the E2F1CM-DP1CM heterodimer
using a strand-loop-helix motif (residues 829–852) and an1098 Cell 123, 1093–1106, December 16, 2005 ª2005 Elsevier Inextended segment (853–861). The RbC rS1 strand binds
through six b sheet backbone hydrogen bonds (residues
831–835) to the E2F eS2 strand and through van der Waalsc.
contacts (Ile831, Val833, and Ile835) to hydrophobic resi-
dues from E2F1, DP1, and RbC rH1 (Figure 4A). The rH1 he-
lix, which is amphipathic, makes multiple high-density van
der Waals contacts (rH1 residues Phe845, Ile848, Met851,
and Val852) to eS2 and dS4 residues in the exposed hydro-
phobic core of the b sandwich (Figure 4A). In addition, side
chains from the polar face of rH1 make hydrogen bonds
with backbone and side chain groups from DP1. For exam-
ple, the side chain of Asn 849, invariant among Rb orthologs,
makes bidentite hydrogen bonds with the backbone amide
and carbonyl groups of Ile 293 of DP1 (Figure 4A). The inter-
molecular van der Waals and hydrogen bond contacts made
by RbC are distributed approximately equally between E2F1
Figure 3. Structural and Biochemical Data Show E2Fs Prefer
to Form Heterodimers with DP over Homodimers
(A) Close-up view of the interface between the coiled-coil and b sandwich
domains that is formed by interactions between nonanalogous structural
elements in E2F1 and DP1. These interactions, along with additional inter-
actions in the coiled coil and the b sandwich (data not shown), indicate
that an E2F homodimer would be less stable and structurally distinct
from the heterodimer. Hydrogen bonds are marked by white dotted lines.
(B) Ten micromolar of purified His6E2F1
CM was incubated overnight at
37ºC with 10 mM untagged E2F1CM-DP1CM or E2F1CM alone and ana-
lyzed by Ni2+ precipitation as in Figure 1B.Celland DP1 atoms. The loop in between the rS1 strand and rH1
helix of RbCcore provides only a few minor intermolecular
contacts (Figure 4A).
Following the rH1 helix, the RbC chain loops around the
end of the b sandwich and a 7 residue extended segment
makes additional hydrogen bonds with DP1 backbone and
side chain groups (Figure 4A). After this extended segment,
the last thirteen residues in the RbC construct used in crystal-
lization (862–874) extend to and pack against another E2F1-
DP1 complex related by a crystallographic 2-fold rotation
symmetry. Deletion of these thirteen amino acids does not af-
fect the affinity of RbC for the E2F1-DP1 complex (Figure 1B).
The structure of the RbCcore-E2F1CM-DP1CM interface is
in accord with our biochemical data showing that RbC bind-
ing is an activity common to both the E2F1 and E2F4 subfa-
milies. The E2F1 and DP1 residues that contact RbCcore are
either conserved or conservatively substituted in E2F and DP
paralogs (Figures 2B and 4A), and as discussed earlier, the
interactions that form the E2F1-DP1 heterodimer involve res-
idues conserved among E2F and DP paralogs (Figures 2B
and 3A).
Inspection of the p107 C-terminal domain in light of the
structure reveals that residues 999 to 1023 may represent
a motif similar to RbCcore. This p107 sequence is evolution-
arily conserved in p107 and p130 orthologs and is predicted
to adopt a strand-loop-helix structure (Supplemental Data,
Section 4). Most of the key E2F-DP interacting residues
of RbCcore, such as Asn 849 that makes a pair of hydro-
gen bonds to DP1, are either conserved or conservatively
substituted in this p107 segment (e.g., Asn 1018; Fig-
ure 2B). That residues 999 to 1023 of p107 are functionally
analogous to RbCcore is supported by the observation that
deletion of residues 1018–1068 compromises the ability
of p107 to coimmunoprecipitate endogenous E2F from
p107-transfected Saos2 cells (Zhu et al., 1995).
RbCcore Binding Requires E2F1-DP1
Heterodimerization
The structure indicates that the binding of RbCcore to E2F1
should strictly depend on the presence of DP1. To confirm
this dependence, we incubated either 10 mM His6-tagged
E2F1CM or 10 mM heterodimeric His6E2F1
CM-DP1CM with
100 mM RbC814–874 and assayed for complex formation us-
ing the Ni2+ precipitation assay. Figure 4B shows that the
resin containing His6E2F1
CM-DP1CM had approximately
a 1 molar ratio of RbC814–874 eluted (Figure 4B, lane 4),
whereas the resin containing His6E2F1
CM alone had only
trace amounts of RbC814–874 eluted (Figure 4B, lane 6).
In addition, we could not detect any ITC heat signal when
RbC814–874 was added to E2F1CM in the absence of
DP1CM (Supplemental Data, Section 1). The dependence
of RbCcore binding on DP1 observed here accounts for pre-
vious observations that heterodimerization of E2F with DP in-
creases Rb and p107 binding in vitro and in vivo (Bandara
et al., 1994; Beijersbergen et al., 1994; Helin et al., 1993b;
Krek et al., 1993). Furthermore, the lack of DP in initial inves-
tigations of the Rb-E2F interaction may explain why the inter-
action described here was overlooked (Flemington et al.,
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Figure 4. RbCcore-E2F1CM-DP1CM Interactions and the Requirement of DP1 for RbCcore Binding
(A) Close-up views of the interactions between RbCcore (orange) and E2F1CM(red)-DP1CM (blue) in two orthogonal orientations, showing that the interactions
RbCcore makes are distributed approximately equally between E2F1 and DP1.
(B) Ten micromolar of purified His6E2F1
CM or 10 mM of purified His6E2F1
CM-DP1CM were incubated with 100 mM RbC814–874 and analyzed by Ni2+ precip-
itation as in Figure 1B.The Secondary RbCnter-E2FCM-DPCM Interaction
Is Negatively Regulated by Phosphorylation
of Ser 788/Ser 795
RbC contains six conserved Cdk-Cyclin sites, clustered in
pairs, which are phosphorylated during G1 progression
and the G1-S transition. Of these sites, the Ser 788/Ser
795 pair maps to the RbCnter secondary E2FCM-DPCM inter-
acting motif, and the Ser 807/Ser 811 and Thr 821/Thr 826
pairs map to the region between RbCnter and RbCcore that
our data show is uninvolved in E2FCM-DPCM binding. An ad-
ditional site (Ser 780) is in the 771–785 segment at the end of
the pocket domain that we included in our initial binding
studies. These sites have been probed extensively by muta-
genesis, but if and how they affect the phosphorylation-
induced release of E2F has not been clear (Brown et al.,
1999; Harbour et al., 1999; Knudsen and Wang, 1996;
Knudsen and Wang, 1997). Our finding that the region encom-
passing Ser 788/Ser 795 makes up the RbCnter secondary
E2FCM-DPCM binding site raised the possibility that phos-
phorylation of Ser 788/Ser 795 affects the RbCnter-E2FCM-
DPCM interaction and contributes to the release of E2F-DP.
To investigate this possibility, we first asked if phosphory-
lation of RbC771–928 affects its affinity for the E2F1CM-DP1CM
complex. We phosphorylated RbC771–928 using Cdk6 bound
to a cyclin from the Kaposi’s sarcoma-associated herpes-
virus, shown to direct Cdk6/Cdk4 to phosphorylate both1100 Cell 123, 1093–1106, December 16, 2005 ª2005 Elsevier IncCdk4/6-CyclinD- and Cdk2-CyclinA/E-specific sites (Godden-
Kent et al., 1997). Use of this kinase resulted in the quantita-
tive phosphorylation of all seven sites in RbC771–928, as con-
firmed by reversed-phase HPLC and mass spectrometry
(data not shown). ITC measurements with HPLC-purified,
phosphorylated RbC771–928 (phosRbC771–928) showed that
phosphorylation reduces the affinity of RbC771–928 for the
E2F1CM-DP1CM complex 22-fold, resulting in a Kd of 2.4 ±
0.2 mM that is comparable to the Kd of the RbC
core (Fig-
ure 5A). Phosphorylation of RbC814–874, which consists of
RbCcore and the preceding region with the Thr 821/Thr
826 phosphorylation sites, had little effect on its Kd for
E2FCM-DPCM (phosRbC814–874 Kd = 2.7 ± 1.1 mM, unphos-
phorylated RbC814–874 Kd = 4.8 ± 0.9 mM; Figure 5A). Taken
together, these data indicate that the secondary RbCnter-
E2FCM-DPCM interaction is essentially eliminated by the
phosphorylation of Ser 788 and Ser 795, whereas the
RbCcore interaction is not directly affected by the phosphor-
ylation of any or all of the RbC sites.
Thr 821/Thr 826 Phosphorylation Induces Binding
of RbC to the Pocket
Phosphorylation of RbC blocks the binding of viral proteins
to the LxCxE binding site of the pocket, and mutation of Thr
821 and Thr 826 abolishes this effect (Knudsen and Wang,
1996). Based on these observations, it has been suggested.
that an RbC segment containing the Thr 821/Thr 826 region
may bind to the LxCxE binding site in the pocket intramo-
lecularly (Harbour et al., 1999; Knudsen and Wang, 1996;
Lee et al., 1998). If this interaction indeed occurs, then
the proximity of Thr 821 and Thr 826 to the start of RbCcore
interacting region (residue 829) raises the possibility that
binding of the phosphorylated Thr 821/Thr 826 sequence
to the pocket destabilizes the RbCcore-E2FCM-DPCM inter-
actions.
To address this possibility, we first tested whether phos-
phorylation of RbC814–874 induces binding to the Rb pocket
using the Ni2+ precipitation assay. We incubated either
10 mM His6RbC
814–874 or 10 mM phosHis6RbC
814–874 with
10 mM Rb pocket (residues 372–787). Under these condi-
tions, phosHis6RbC
814–874 binds approximately 35% the
Rb pocket input, whereas His6RbC
814–874 binds only a trace
amount (<2% of input, compare lanes 4 and 6 in Figure 5B).
These data indicate that phosphorylation of Thr 821 and
Thr 826 is sufficient to induce the binding of RbC814–874 to
the Rb pocket.
We next addressed whether phosphorylation of the nearby
Ser 807 and Ser 811 sites, whose phosphorylation regulates
the binding of the c-Abl kinase to Rb (Knudsen and Wang,
1996), can also induce binding to the Rb pocket. We incu-
bated 10 mM Rb pocket with either 10 mM His6RbC
801–874,
which contains all four phosphorylation sites, or with
10 mM RbC801–874(A821/A826), where Thr 821 and Thr 826
are mutated to alanines, and assayed binding using the
Ni2+ precipitation assay. Figure 5C shows that whereas
phosRbC801–874 binds approximately 35% of the input Rb
pocket, phosRbC801–874(A821/A826) binds only trace
amounts (compare lanes 4 and 6). These data demonstrate
that specific phosphorylation at Thr 821 and Thr 826 is re-
quired for the binding of RbC to the pocket.
We next quantitated the binding of the Rb pocket to vari-
ous RbC fragments using ITC. We found that whereas
phosRbC814–874 binds the Rb pocket with a Kd of 10 ±
1 mM, unphosphorylated RbC814–874 gave no signal (Fig-
ure 5D). Consistent with results of the Ni2+ precipitation ex-
periments, additional phosphorylation of Ser 807 and Ser
811 in a longer phosRbC801–874 peptide or phosphorylation
of all six sites in phosRbC786–874 did not significantly affect
the affinity (Kd = 8 ± 1 mM and Kd = 8 ± 4 mM, respectively;
Figure 5C). These results indicate that phosphorylation of
Thr 821 and Thr 826 is necessary and sufficient to induce
the binding of RbC814–874 to the Rb pocket and that phos-
phorylation of the other sites in RbC786–874 does not affect
this interaction.
The Rb pocket binds the E2F transactivation domain and
the viral LxCxE motif at distinct sites (Lee et al., 2002; Lee
et al., 1998; Xiao et al., 2003). To elucidate whether phos-
phorylated RbC binds the pocket at either of these sites,
we tested if an HPV E7 LxCxE peptide, shown to bind the
Rb pocket with a 0.11 mM Kd, or an E2F4 transactivation
domain peptide could compete with the binding of phos-
phorylated RbC to the Rb pocket. Using the Ni2+ precipita-
tion assay with all proteins at 10 mM, we found that the pres-
ence of 100 mM E2F4 transactivation-domain peptide does
not affect the amount of Rb pocket that is bound byCellHis6phosRbC
814–874, but the presence of 100 mM LxCxE
peptide results in only trace amounts of Rb pocket being
bound by His6phosRbC
814–874 (Figure 5E). This assay dem-
onstrates that the binding sites for the phosphorylated RbC
and for the viral LxCxE motif on the Rb pocket overlap sub-
stantially.
Binding of Phosphorylated RbC to the Pocket
and to E2F1CM-DP1CM Is Mutually Exclusive
Having established that phosphorylation of Thr 821/Thr 826
induces the binding of RbC to the Rb pocket, we next asked
whether this interaction can interfere with the binding of
RbCcore to the E2FCM-DPCM heterodimer. We preincubated
increasing amounts (10 to 60mM) of the Rb pocket with a con-
stant amount (10 mM) of His6E2F
CM-DPCM, then added
phosRbC814–874 (10 mM) followed by Ni2+ precipitation and
elution. In keeping with the ITC results, quantitation of the
Coomassie-stained bands shows that in the absence of
the Rb pocket His6E2F1
CM-DP1CM binds 25% of the
phosRbC814–874 (Figure 5F, lane 2 and plot). The presence
of 10 mM Rb pocket reduces the amount of phosRbC814–874
coeluting with His6E2F1
CM-DP1CM to 14% (Figure 5F, lane
4), and the presence of 30 and 60 mM Rb pocket reduces it
further to 11% and 3%, respectively (Figure 5F, lanes 6 and
8). These results indicate that the binding of RbC to the Rb
pocket and to E2F1CM-DP1CM is mutually exclusive.
The simplest model that can account for this observation
is that the Rb pocket and E2FCM-DPCM bind to partially over-
lapping regions of RbC, although other models involving ste-
ric or structural constraints are possible. To address this, we
tested the binding of the Rb pocket either to phosRbC818–839,
which consists of the phosphorylated Thr 821/Thr 826
segment and the strand-loop region of RbCcore, and to
phosRbC818–828, which lacks any RbCcore residues. ITC
measurements show that phosRbC818–839 binds to the Rb
pocket with a 7 ± 1 mM Kd, which is identical, within experi-
mental error, to the Kd of the hyperphosphorylated entire
RbC, whereas phosRbC818–828 gave no ITC signal (Figure
5D). These data demonstrate that part of the E2F1CM-
DP1CM interacting region of RbCcore is also involved in
binding to the Rb pocket, indicating that the binding of phos-
phorylated RbC to the pocket destabilizes the RbCcore-
E2F1CM-DP1CM interactions through direct competition. In
the context of full-length Rb, the RbC-Rb pocket association
will be intramolecular, which should allow the pocket to
compete effectively with the RbCcore-E2F1CM-DP1CM inter-
actions and contribute to E2F release on phosphorylation.
This conclusion is supported by a recent study showing
that mutation of a patch of conserved lysine residues at
the LxCxE binding site of the Rb pocket interferes with
E2F-release by phosphorylation (Brown and Gallie, 2002).
DISCUSSION
Our structural and biochemical data establish that the C-ter-
minal domains of the pocket proteins have a general E2F-DP
binding activity. This activity resides in two segments, with
a 36 residue RbCcore segment contributing the bulk of the
binding energy with a Kd of 5 mM and a 15 residue RbC
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Figure 5. Phosphorylation of RbC Disrupts Binding to E2F1CM-DP1CM
(A) ITC measurements show that phosphorylation of all seven Cdk-Cyclin sites reduces the RbC-E2F1CM-DP1CM Kd 22-fold, essentially eliminating the
RbCnter-E2F1CM-DP1CM interactions, but does not affect the RbCcore-E2F1CM-DP1CM interactions.
(B) Phosphorylation of Thr 821/Thr 826 in RbC814–874 (phosRbC814–874) induces binding to the Rb pocket. Ten micromolar of purified His6RbC
814–874 or
His6phosRbC
814–874 were incubated with 10 mM of purified Rb pocket and analyzed by Ni2+ precipitation assay as in Figure 1B.
(C) Binding of RbC to the Rb pocket is specific for phosphorylated Thr 821/Thr 826 (lane 6), and phosphorylated Ser 807/Ser 811 cannot substitute (lane 10).
Ten micromolar of purified Rb pocket was incubated with either wild-type RbC801–874 (His6RbC
801–874[WT] or His6phosRbC
801–874 [WT]) or the correspond-
ing proteins where Thr 821 and Thr 826 were mutated to alanine (His6RbC
801–874[A821/A826] and His6phosRbC
801–874[A821/A826]). Reactions were an-
alyzed as in (B).
(D) ITC-determined Kd values showing that RbC
818–839 consisting of the phosphorylated Thr 821/Thr 826 segment and the strand-loop region of RbCcore is
necessary and sufficient to induce pocket binding.1102 Cell 123, 1093–1106, December 16, 2005 ª2005 Elsevier Inc.
segment increasing the affinity 36-fold, resulting in a Kd of
110 nM (Figures 1D and 6). This affinity is comparable to
the 340–400 nM Kd values, determined by ITC, for the asso-
ciation of the Rb pocket domain with the E2F1 transactiva-
tion domain (Lee et al., 1998; Xiao et al., 2003), indicating
that the RbC-E2F1CM-DP1CM interactions are likely to be
as important as the Rb pocket-E2F transactivation domain
interactions for Rb-E2F-DP assembly.
Our biochemical data show that RbC can bind to the
CC-MB domains of E2F1-DP1, E2F2-DP2, E2F4-DP2, and
E2F1-DP5 comparably (Figure 1B), and our ITC data dem-
onstrate that the RbC-E2F1CM-DP1CM and RbC-E2F4CM-
DP2CM complexes have essentially identical Kd values (Fig-
ure 1C). Together with the conservation of the Rb-E2F-DP
contacts in the crystal structure, our findings indicate that
the RbC-E2FCM-DPCM interaction is general across mem-
bers of both E2F-DP subfamilies. This common interaction
mirrors the similar affinities of the Rb pocket domain for the
transactivation domains of the two E2F subfamilies (Lee
et al., 2002; Lee et al., 1998; Xiao et al., 2003). Our data
also show that the C-terminal domain of p107 binds to
E2F4CM-DP1CM with high affinity but binds to E2F1CM-
DP1CM6-fold weaker (Figure 1C). This result indicates that
the preferential association of p107 with E2F4 is due, at least
in part, to the C-terminal E2F-DP binding activity of p107.
The general E2F-DP binding activity demonstrated here
explains the well-established but poorly understood require-
ment for the C-terminal domains of the pocket proteins for
high-affinity E2F-DP binding (Hiebert, 1993; Hiebert et al.,
1992; Qin et al., 1992). It also can account, at least in part,
for the findings that the C-terminal domains of the pocket
proteins are absolutely required for full repression of E2F-
responsive promoters and for growth suppression (Qin
et al., 1992; Zhu et al., 1995). Finally, considering recent
work identifying interactions between E2F MB domains
and other transcription factors that result in gene-specific
activation (Giangrande et al., 2004; Schlisio et al., 2002), it
is possible that the RbC-MB interaction described here pro-
vides an additional mechanism by which Rb can control E2F
transcriptional output.
The RbC-E2FCM-DPCM interaction critically depends on
E2F-DP heterodimerization. Our structural data show that
the contacts RbC makes to E2F1 and DP1 are comparable
in number and suggest that the E2F1CM-DP1CM structure
would not form by E2F1CM alone (Figures 3 and 4). In sup-
port, our biochemical data show that E2F1CM does not
bind RbC detectably (Figure 4B), and E2F1CM alone does
not homodimerize stably (Figure 3B; Supplemental Data,
Section 2). The requirement for DP thus explains why
many past studies, which typically were carried out withCell 1E2F alone, failed to find evidence for a direct interaction be-
tween RbC and E2F.
A general interaction between the C-terminal domains of
the pocket proteins and E2F-DP heterodimers was antici-
pated by studies of the mechanism through which viral pro-
teins displace E2F (Jost et al., 1996; O’Connor and Hearing,
1994; Patrick et al., 1994; Raychaudhuri et al., 1991; Zalvide
et al., 1998). However, the only previous direct experimental
Figure 6. Model for the Phosphorylation-Induced Dissocia-
tion of the RbC-E2FCM-DPCM Interfaces, Incorporating Re-
ported Data on the Rb Pocket-E2F TD Association
Unphosphorylated Rb binds E2F-DP heterodimers through at least three
interactions. The Rb pocket binds to the E2F TD, and RbCnter and RbCcore
bind to the E2FCM-DPCM domains. In early G1, phosphorylation of Ser
788/Ser 795 by Cdk4-CyclinD induces dissociation of RbCnter reducing
the overall RbC-E2FCM-DPCM affinity. Subsequent phosphorylation of
Thr 821/Thr 826 induces an intramolecular interaction between RbC
and the Rb pocket that excludes the binding of RbCcore to E2FCM-
DPCM Phosphorylation of other sites in the pocket likely disrupts the bind-
ing of the E2F transactivation domain.(E) Binding of phosRbC814–874 to the Rb pocket is competed by the HPV E7 LxCxE peptide but not by the E2F4 TD peptide. The same assay was performed
as in (B), except for the addition of a 10-fold molar excess of either an HPV E7 LxCxE peptide or an E2F4 TD peptide.
(F) Binding of phosRbC814–874 to the Rb pocket excludes binding of phosRbC814–874 to E2FCM-DPCM. Ten micromolar of His6E2F1
CM-DP1CM was mixed
with phosRbC814–874 in the absence or presence of increasing concentrations of Rb pocket. Percent RbC bound, calculated from the integrated intensity of
Coomassie-stained bands as (RbC bound)/(RbC bound + RbC unbound) for each pair of lanes, decreases with increasing Rb pocket concentration. Per-
cent His6E2F1
CM bound, calculated analogously, remains constant. Data from two separate experiments were averaged, and the error bars correspond to
the standard deviations of the two measurements. A small amount of Rb pocket was observed in the bound fractions independent of His6E2F1
CM-DP1CM
(lane 10). We presume that it is a result of nonspecific interactions between the Rb pocket and the Ni2+ resin.23, 1093–1106, December 16, 2005 ª2005 Elsevier Inc. 1103
evidence for this idea has been a recent study by Dick and
Dyson (2003), in which an interaction between an Rb
C-terminal fragment and E2F1-DP1 was shown to be spe-
cific for E2F1 and responsible for the unique ability of E2F1
to induce apoptosis. Their conclusions were based in part
on the findings that a GST-tagged Rb792–928 fragment,
which lacks part of the RbCnter motif identified here, binds
to HA-tagged E2F1-DP1 as well as HA-E2F1(1–374)-DP1
lacking the transactivation domain, but it does not bind HA-
E2F4-DP1 and binds HA-E2F2-DP1 100-fold weaker than
HA-E2F1-DP1 in an indirect assay. It is not clear why these
findings differ from our results demonstrating that the RbC-
E2FCM-DPCM interaction is common to both E2F subfami-
lies. The use of mammalian cell-expressed proteins and
the presence of cell extracts in the binding assays of Dick
and Dyson (2003) might have resulted in differentially phos-
phorylated proteins and contributed to the differences. Dif-
ferences in the protein fragment boundaries used in the
two studies might also have been a contributing factor. In
this respect, it is possible that the interaction described by
Dick and Dyson (2003) is only partially overlapping with or
is distinct from the one demonstrated here (Supplemental
Data, Section 5).
The RbC-E2FCM-DPCM interaction described here also
provides a basis for the first mechanistic description of how
the Rb-E2F-DP complex is dissociated by phosphorylation,
a key event in the control of the G1-S transition (Figure 6).
We show that phosphorylation of Ser 788/Ser 795 in RbCnter
essentially eliminates the secondary interaction in the RbC-
E2FCM-DPCM complex, weakening its Kd 22-fold (Figures
5A and 6). Phosphorylation of Ser 795, which is an efficient
Cdk4/6-CyclinD phosphorylation site occurs early in G1
(Connel-Crowley et al., 1997; Lundberg and Weinberg,
1998; Pan et al., 1998), suggesting that the elimination of the
RbCnter-E2FCM-DPCM interaction is an early event in the de-
stabilization of the Rb-E2F-DP complex by phosphorylation.
Our data show that the remaining RbCcore-E2FCM-DPCM
interactions are eliminated indirectly by the subsequent
phosphorylation of the Thr 821/Thr 826 Cdk2-CyclinE/A
sites. This phosphorylation induces the binding of pThr
821/pThr 826 and part of the following RbCcore strand-loop
segment to the Rb pocket in a manner that directly competes
with binding of RbCcore to E2FCM-DPCM (Figure 6).
The phosphorylation-mediated dissociation of RbC from
E2FCM-DPCM should destabilize the overall Rb-E2F-DP com-
plex significantly, consistent with the Rb pocket-E2F transac-
tivation domain interaction not being sufficient for full tran-
scriptional repression and for growth suppression (Hiebert,
1993; Hiebert et al., 1992; Qin et al., 1992). However, the
Rb pocket-E2F transactivation domain interactions are also
likely regulated by phosphorylation. Phosphorylation of Ser
608/Ser 612 in the Rb pocket inhibits the binding of E2F1
in a manner that is dependent on the presence of the Rb
N-terminal domain (Knudsen and Wang, 1997). This obser-
vation suggests that a phosphorylation-induced intramo-
lecular interaction between the Rb pocket and N-terminal
domains, reminiscent of the pocket-RbC interaction demon-
strated here, may negatively regulate E2F transactivation
domain binding.1104 Cell 123, 1093–1106, December 16, 2005 ª2005 Elsevier IOur findings also establish that at least one reason for the
existence of the LxCxE binding site is intramolecular interac-
tions. The crystal structure of the Rb pocket domain bound
to the HPV E7 LxCxE motif showed that the LxCxE binding
site is one of the features best conserved in Rb orthologs
and the p107/p130 paralogs (Lee et al., 1998). Although sev-
eral cellular proteins have been reported to bind Rb through
LxCxE-like sequences, none have been demonstrated to
bind to the LxCxE site directly and with an affinity commen-
surate with the conservation of this site. In fact, a recent
study showed that mutations in the Rb pocket that prevent
the binding of LxCxE peptides do not affect the ability of
Rb to bind to HDAC1, repress E2F-responsive promoters
and arrest the cell cycle (Dick et al., 2000). The pThr 821/
pThr 826-strand-loop RbC segment that our data show
binds to the LxCxE binding site is highly conserved in Rb or-
thologs and a similar motif appears to be present in p107 as
well (Figure 2B). This intramolecular interaction may well ac-
count, at least in part, for the presence and conservation of
the LxCxE binding site in the pocket proteins.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Phosphorylation
Recombinant human E2FCM and DPCM proteins (E2F1 residues 200–301,
E2F2 residues 206–306, E2F4 residues 91–198, E2F5 residues 125–232,
DP1 residues 199–350, and DP2 residues 153–307) were coexpressed
as His6 and glutathione S-transferase (GST) fusion proteins, respectively,
in Escherichia coli. Coexpression was achieved as reported previously ei-
ther by transforming with one plasmid containing a dicistronic message or
with two plasmids containing distinct origins of replication (p15A and
pBR322; Stebbins et al., 1999). The E2FCM-DPCM complexes were puri-
fied first with Ni2+-NTA then with glutathione Sepharose affinity chroma-
tography, and following cleavage of the tags where indicated, by anion-
exchange chromatography. His6-tagged human RbC, p107C, and
E2F1 transactivation-domain (372–437) polypeptides were expressed in
E. coli. They were first purified by Ni2+ affinity chromatography in the pres-
ence of 6 M urea, then by ion-exchange chromatography in the absence
of urea. Where indicated, His6-tag cleavage was followed by repurification
with ion-exchange chromatography. The human Rb pocket domain (res-
idues 372–787) was purified as described previously, except the linker
between the two domains was intact (Lee et al., 1998). RbC polypeptides
were phosphorylated with an 100 nM Cdk6-herpesvirus cyclin kinase
preparation (Jeffrey et al., 2000), at 37ºC in a buffer of 50 mM Tris-HCl,
10 mM MgCl2, 0.1 mM Na3VO4 (pH 7.0), with 1mM ATP per phosphory-
lation site and 0.1 mM polypeptide. Phosphorylation was nearly quan-
titative, as determined by reverse-phase HPLC and mass spectrom-
etry. Following phosphorylation, the polypeptides were repurified by
reversed-phase HPLC. The HPV E7 LxCxE (residues 19–31), E2F4 trans-
activation domain (390–407), RbC818–839, and RbC818–828 peptides were
synthesized, N-terminal acetylated, and C-terminal amidated and purified
by reversed-phase HPLC. Protein and peptide concentrations were de-
termined from A280 measurements using calculated extinction coeffi-
cients.
Crystallization
Purified RbC (residues 829–874) was mixed with purified E2F1CM-DP1CM
complex at a 2:1 molar ratio, and the ternary complex was isolated using
Superdex75gel-filtrationchromatographyandconcentratedto20mg/ml1
in a buffer of 25 mM Tris-HCl, 200 mM NaCl, and 5 mM DTT (pH 8.0). Crys-
tals were grown by the hanging-drop vapor diffusion method at room tem-
perature from 100 mM sodium citrate, 1.6 M ammonium sulfate, and 8%
w/v PEG 400 (pH 5.5). Details of X-ray diffraction data collection and anal-
ysis are reported in Supplemental Data, Section 6.nc.
Ni2+-His6 Affinity Precipitation Assays
Indicated proteins were incubated at room temperature for 5 min in 40 ml
of binding buffer consisting of 50 mM Tris-HCl, 75 mM NaCl, and 15 mM
imidazole (pH 7.1) prior to addition of 15ml Ni2+-NTA resin. After 5 min, the
resin was spun down, and the 40 ml supernatant, marked as the un-
bound (U) fraction in the figures, was removed. The resin was then washed
twice with 1 ml of binding buffer and the Ni2+ bound proteins were eluted
with 40 ml of binding buffer supplemented with 600 mM imidazole. One-
fourth of each of the supernatant and eluted fractions, marked as the
unbound (U) and bound (B) fractions, respectively, on the figures, were
fractionated by SDS-PAGE and were stained with Coomassie. The pro-
tein concentrations used in the incubations were all 10 mM, except when
indicated otherwise. For Figure 3B, proteins were incubated overnight at
37ºC to allow for dimer exchange. The Rb pocket competition titration
(Figure 5F) was quantified using ImageGauge software.
Isothermal-Titration Calorimetry
Isothermal calorimetry experiments were performed with a Micro Calorim-
etry System (Microcal Inc.). Typically, 0.3–1 mM RbC, phosRbC, or p107
polypeptides were injected into a 20–50 mM solution of E2FCM-DPCM
or Rb pocket. Experiments were done at 25ºC in 50 mM Tris-HCl,
100 mM NaCl, and 2 mM DTT (pH 7.0). Titration data were analyzed using
the MicroCal Origin software, and the reported binding constants and
standard deviations were derived from two to four independent measure-
ments. Sample titration data are shown in Supplemental Data, Section 1.
Supplemental Data
Supplemental Data include three figures and supplemental text and can
be found with this article online at http://www.cell.com/cgi/content/full/
123/6/1093/DC1/.
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